Port Wine
Port Wine market is segmented by Type and by Application. Players, stakeholders, and other partic ... Read More
Global Hemoglobinopathies Market Insights and Forecast to 2028
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemoglobinopathies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Transfusion
1.2.3 Iron Chelation Therapy
1.2.4 Bone Marrow Transplant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Hemoglobinopathies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Testing
1.3.3 Genetic Testing
1.3.4 Pre-Implantation Genetic Diagnosis (PGD)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hemoglobinopathies Market Perspective (2017-2028)
2.2 Hemoglobinopathies Growth Trends by Region
2.2.1 Hemoglobinopathies Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hemoglobinopathies Historic Market Size by Region (2017-2022)
2.2.3 Hemoglobinopathies Forecasted Market Size by Region (2023-2028)
2.3 Hemoglobinopathies Market Dynamics
2.3.1 Hemoglobinopathies Industry Trends
2.3.2 Hemoglobinopathies Market Drivers
2.3.3 Hemoglobinopathies Market Challenges
2.3.4 Hemoglobinopathies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemoglobinopathies Players by Revenue
3.1.1 Global Top Hemoglobinopathies Players by Revenue (2017-2022)
3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2017-2022)
3.2 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemoglobinopathies Revenue
3.4 Global Hemoglobinopathies Market Concentration Ratio
3.4.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2021
3.5 Hemoglobinopathies Key Players Head office and Area Served
3.6 Key Players Hemoglobinopathies Product Solution and Service
3.7 Date of Enter into Hemoglobinopathies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemoglobinopathies Breakdown Data by Type
4.1 Global Hemoglobinopathies Historic Market Size by Type (2017-2022)
4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2023-2028)
5 Hemoglobinopathies Breakdown Data by Application
5.1 Global Hemoglobinopathies Historic Market Size by Application (2017-2022)
5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hemoglobinopathies Market Size (2017-2028)
6.2 North America Hemoglobinopathies Market Size by Type
6.2.1 North America Hemoglobinopathies Market Size by Type (2017-2022)
6.2.2 North America Hemoglobinopathies Market Size by Type (2023-2028)
6.2.3 North America Hemoglobinopathies Market Share by Type (2017-2028)
6.3 North America Hemoglobinopathies Market Size by Application
6.3.1 North America Hemoglobinopathies Market Size by Application (2017-2022)
6.3.2 North America Hemoglobinopathies Market Size by Application (2023-2028)
6.3.3 North America Hemoglobinopathies Market Share by Application (2017-2028)
6.4 North America Hemoglobinopathies Market Size by Country
6.4.1 North America Hemoglobinopathies Market Size by Country (2017-2022)
6.4.2 North America Hemoglobinopathies Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Hemoglobinopathies Market Size (2017-2028)
7.2 Europe Hemoglobinopathies Market Size by Type
7.2.1 Europe Hemoglobinopathies Market Size by Type (2017-2022)
7.2.2 Europe Hemoglobinopathies Market Size by Type (2023-2028)
7.2.3 Europe Hemoglobinopathies Market Share by Type (2017-2028)
7.3 Europe Hemoglobinopathies Market Size by Application
7.3.1 Europe Hemoglobinopathies Market Size by Application (2017-2022)
7.3.2 Europe Hemoglobinopathies Market Size by Application (2023-2028)
7.3.3 Europe Hemoglobinopathies Market Share by Application (2017-2028)
7.4 Europe Hemoglobinopathies Market Size by Country
7.4.1 Europe Hemoglobinopathies Market Size by Country (2017-2022)
7.4.2 Europe Hemoglobinopathies Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemoglobinopathies Market Size (2017-2028)
8.2 Asia-Pacific Hemoglobinopathies Market Size by Type
8.2.1 Asia-Pacific Hemoglobinopathies Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hemoglobinopathies Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hemoglobinopathies Market Share by Type (2017-2028)
8.3 Asia-Pacific Hemoglobinopathies Market Size by Application
8.3.1 Asia-Pacific Hemoglobinopathies Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hemoglobinopathies Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hemoglobinopathies Market Share by Application (2017-2028)
8.4 Asia-Pacific Hemoglobinopathies Market Size by Region
8.4.1 Asia-Pacific Hemoglobinopathies Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hemoglobinopathies Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hemoglobinopathies Market Size (2017-2028)
9.2 Latin America Hemoglobinopathies Market Size by Type
9.2.1 Latin America Hemoglobinopathies Market Size by Type (2017-2022)
9.2.2 Latin America Hemoglobinopathies Market Size by Type (2023-2028)
9.2.3 Latin America Hemoglobinopathies Market Share by Type (2017-2028)
9.3 Latin America Hemoglobinopathies Market Size by Application
9.3.1 Latin America Hemoglobinopathies Market Size by Application (2017-2022)
9.3.2 Latin America Hemoglobinopathies Market Size by Application (2023-2028)
9.3.3 Latin America Hemoglobinopathies Market Share by Application (2017-2028)
9.4 Latin America Hemoglobinopathies Market Size by Country
9.4.1 Latin America Hemoglobinopathies Market Size by Country (2017-2022)
9.4.2 Latin America Hemoglobinopathies Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemoglobinopathies Market Size (2017-2028)
10.2 Middle East & Africa Hemoglobinopathies Market Size by Type
10.2.1 Middle East & Africa Hemoglobinopathies Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hemoglobinopathies Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hemoglobinopathies Market Share by Type (2017-2028)
10.3 Middle East & Africa Hemoglobinopathies Market Size by Application
10.3.1 Middle East & Africa Hemoglobinopathies Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hemoglobinopathies Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hemoglobinopathies Market Share by Application (2017-2028)
10.4 Middle East & Africa Hemoglobinopathies Market Size by Country
10.4.1 Middle East & Africa Hemoglobinopathies Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hemoglobinopathies Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gamida Cell
11.1.1 Gamida Cell Company Details
11.1.2 Gamida Cell Business Overview
11.1.3 Gamida Cell Hemoglobinopathies Introduction
11.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2017-2022)
11.1.5 Gamida Cell Recent Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2017-2022)
11.2.5 Alnylam Pharmaceuticals Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Hemoglobinopathies Introduction
11.3.4 Sanofi Revenue in Hemoglobinopathies Business (2017-2022)
11.3.5 Sanofi Recent Developments
11.4 Sangamo Therapeutics Inc.
11.4.1 Sangamo Therapeutics Inc. Company Details
11.4.2 Sangamo Therapeutics Inc. Business Overview
11.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction
11.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2017-2022)
11.4.5 Sangamo Therapeutics Inc. Recent Developments
11.5 Global Blood Therapeutics
11.5.1 Global Blood Therapeutics Company Details
11.5.2 Global Blood Therapeutics Business Overview
11.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction
11.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2017-2022)
11.5.5 Global Blood Therapeutics Recent Developments
11.6 Bluebird Bio
11.6.1 Bluebird Bio Company Details
11.6.2 Bluebird Bio Business Overview
11.6.3 Bluebird Bio Hemoglobinopathies Introduction
11.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2017-2022)
11.6.5 Bluebird Bio Recent Developments
11.7 Emmaus Life Sciences Inc.
11.7.1 Emmaus Life Sciences Inc. Company Details
11.7.2 Emmaus Life Sciences Inc. Business Overview
11.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction
11.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2017-2022)
11.7.5 Emmaus Life Sciences Inc. Recent Developments
11.8 Prolong Pharmaceuticals
11.8.1 Prolong Pharmaceuticals Company Details
11.8.2 Prolong Pharmaceuticals Business Overview
11.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction
11.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2017-2022)
11.8.5 Prolong Pharmaceuticals Recent Developments
11.9 Celgene Corporation
11.9.1 Celgene Corporation Company Details
11.9.2 Celgene Corporation Business Overview
11.9.3 Celgene Corporation Hemoglobinopathies Introduction
11.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2017-2022)
11.9.5 Celgene Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hemoglobinopathies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Iron Chelation Therapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Key Players of Others
Table 6. Global Hemoglobinopathies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Hemoglobinopathies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Hemoglobinopathies Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Hemoglobinopathies Market Share by Region (2017-2022)
Table 10. Global Hemoglobinopathies Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Hemoglobinopathies Market Share by Region (2023-2028)
Table 12. Hemoglobinopathies Market Trends
Table 13. Hemoglobinopathies Market Drivers
Table 14. Hemoglobinopathies Market Challenges
Table 15. Hemoglobinopathies Market Restraints
Table 16. Global Hemoglobinopathies Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Hemoglobinopathies Revenue Share by Players (2017-2022)
Table 18. Global Top Hemoglobinopathies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathies as of 2021)
Table 19. Ranking of Global Top Hemoglobinopathies Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Hemoglobinopathies Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemoglobinopathies Product Solution and Service
Table 23. Date of Enter into Hemoglobinopathies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemoglobinopathies Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Hemoglobinopathies Revenue Market Share by Type (2017-2022)
Table 27. Global Hemoglobinopathies Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Hemoglobinopathies Revenue Market Share by Type (2023-2028)
Table 29. Global Hemoglobinopathies Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Hemoglobinopathies Revenue Share by Application (2017-2022)
Table 31. Global Hemoglobinopathies Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Hemoglobinopathies Revenue Share by Application (2023-2028)
Table 33. North America Hemoglobinopathies Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Hemoglobinopathies Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Hemoglobinopathies Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Hemoglobinopathies Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Hemoglobinopathies Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Hemoglobinopathies Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Hemoglobinopathies Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Hemoglobinopathies Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Hemoglobinopathies Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Hemoglobinopathies Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Hemoglobinopathies Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Hemoglobinopathies Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Hemoglobinopathies Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Hemoglobinopathies Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Hemoglobinopathies Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Hemoglobinopathies Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Hemoglobinopathies Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Hemoglobinopathies Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Hemoglobinopathies Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Hemoglobinopathies Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Hemoglobinopathies Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Hemoglobinopathies Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Hemoglobinopathies Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Hemoglobinopathies Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Hemoglobinopathies Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Hemoglobinopathies Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Hemoglobinopathies Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Hemoglobinopathies Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Hemoglobinopathies Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Hemoglobinopathies Market Size by Country (2023-2028) & (US$ Million)
Table 63. Gamida Cell Company Details
Table 64. Gamida Cell Business Overview
Table 65. Gamida Cell Hemoglobinopathies Product
Table 66. Gamida Cell Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 67. Gamida Cell Recent Developments
Table 68. Alnylam Pharmaceuticals Company Details
Table 69. Alnylam Pharmaceuticals Business Overview
Table 70. Alnylam Pharmaceuticals Hemoglobinopathies Product
Table 71. Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 72. Alnylam Pharmaceuticals Recent Developments
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Hemoglobinopathies Product
Table 76. Sanofi Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 77. Sanofi Recent Developments
Table 78. Sangamo Therapeutics Inc. Company Details
Table 79. Sangamo Therapeutics Inc. Business Overview
Table 80. Sangamo Therapeutics Inc. Hemoglobinopathies Product
Table 81. Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 82. Sangamo Therapeutics Inc. Recent Developments
Table 83. Global Blood Therapeutics Company Details
Table 84. Global Blood Therapeutics Business Overview
Table 85. Global Blood Therapeutics Hemoglobinopathies Product
Table 86. Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 87. Global Blood Therapeutics Recent Developments
Table 88. Bluebird Bio Company Details
Table 89. Bluebird Bio Business Overview
Table 90. Bluebird Bio Hemoglobinopathies Product
Table 91. Bluebird Bio Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 92. Bluebird Bio Recent Developments
Table 93. Emmaus Life Sciences Inc. Company Details
Table 94. Emmaus Life Sciences Inc. Business Overview
Table 95. Emmaus Life Sciences Inc. Hemoglobinopathies Product
Table 96. Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 97. Emmaus Life Sciences Inc. Recent Developments
Table 98. Prolong Pharmaceuticals Company Details
Table 99. Prolong Pharmaceuticals Business Overview
Table 100. Prolong Pharmaceuticals Hemoglobinopathies Product
Table 101. Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 102. Prolong Pharmaceuticals Recent Developments
Table 103. Celgene Corporation Company Details
Table 104. Celgene Corporation Business Overview
Table 105. Celgene Corporation Hemoglobinopathies Product
Table 106. Celgene Corporation Revenue in Hemoglobinopathies Business (2017-2022) & (US$ Million)
Table 107. Celgene Corporation Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathies Market Share by Type: 2021 VS 2028
Figure 2. Blood Transfusion Features
Figure 3. Iron Chelation Therapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Others Features
Figure 6. Global Hemoglobinopathies Market Share by Application: 2021 VS 2028
Figure 7. Blood Testing Case Studies
Figure 8. Genetic Testing Case Studies
Figure 9. Pre-Implantation Genetic Diagnosis (PGD) Case Studies
Figure 10. Others Case Studies
Figure 11. Hemoglobinopathies Report Years Considered
Figure 12. Global Hemoglobinopathies Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Hemoglobinopathies Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Hemoglobinopathies Market Share by Region: 2021 VS 2028
Figure 15. Global Hemoglobinopathies Market Share by Players in 2021
Figure 16. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathies as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Hemoglobinopathies Revenue in 2021
Figure 18. North America Hemoglobinopathies Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Hemoglobinopathies Market Size Market Share by Type (2017-2028)
Figure 20. North America Hemoglobinopathies Market Size Market Share by Application (2017-2028)
Figure 21. North America Hemoglobinopathies Market Size Share by Country (2017-2028)
Figure 22. United States Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Hemoglobinopathies Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Hemoglobinopathies Market Size Market Share by Type (2017-2028)
Figure 26. Europe Hemoglobinopathies Market Size Market Share by Application (2017-2028)
Figure 27. Europe Hemoglobinopathies Market Size Share by Country (2017-2028)
Figure 28. Germany Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Hemoglobinopathies Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Hemoglobinopathies Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Hemoglobinopathies Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Hemoglobinopathies Market Size Share by Region (2017-2028)
Figure 38. China Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Hemoglobinopathies Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Hemoglobinopathies Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Hemoglobinopathies Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Hemoglobinopathies Market Size Share by Country (2017-2028)
Figure 48. Mexico Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Hemoglobinopathies Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Hemoglobinopathies Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Hemoglobinopathies Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Hemoglobinopathies Market Size Share by Country (2017-2028)
Figure 54. Turkey Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Hemoglobinopathies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 58. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 59. Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 60. Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 61. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 62. Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 63. Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 64. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 65. Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gamida Cell Alnylam Pharmaceuticals Sanofi Sangamo Therapeutics Inc. Global Blood Therapeutics Bluebird Bio Emmaus Life Sciences Inc. Prolong Pharmaceuticals Celgene Corporation